Long-term equity investments are accounted for using the equity method. Can impairment provisions be made?

Long-term equity investments accounted for under the equity method can indeed be subject to impairment provisions, a critical accounting mechanism to ensure the carrying value of the investment does not exceed its recoverable amount. Under both International Financial Reporting Standards (IFRS) and US Generally Accepted Accounting Principles (GAAP), the equity method investment is not subject to amortization but must be tested for impairment when there is an indication that its value may have declined below its carrying amount on the investor's balance sheet. The core principle is that the investment, initially recorded at cost and subsequently adjusted for the investor's share of the investee's profits or losses and dividends, must reflect a faithful representation of its economic value. An impairment loss is recognized when there is objective evidence that a decline in value is other than temporary, leading to a write-down of the asset's carrying value with a corresponding charge to the income statement.

The specific impairment testing mechanics differ between the two major accounting frameworks, which is a key operational distinction. Under IFRS, the investment is assessed under IAS 36 *Impairment of Assets* as a single asset, unless it is part of a cash-generating unit. The recoverable amount is determined as the higher of its fair value less costs of disposal and its value in use, with any excess of carrying amount over this recoverable amount recognized as an impairment loss. Under US GAAP, the process is governed by ASC 323 *Investments—Equity Method and Joint Ventures*, which requires an impairment test only when a loss in value is considered other than temporary. This assessment is more qualitative and less formulaic, focusing on the severity and duration of the decline and the investor's ability and intent to hold the investment until recovery. The impairment loss is measured as the difference between the investment's carrying amount and its fair value at the impairment evaluation date.

Recognizing an impairment has direct and significant implications for financial statements and analysis. The immediate effect is a reduction in the asset's book value on the balance sheet and a hit to earnings in the period the impairment is recognized, which can materially impact key profitability metrics. Importantly, under both IFRS and US GAAP, subsequent reversals of impairment losses for equity method investments are generally prohibited, meaning the write-down is permanent even if the investee's fortunes later improve. This asymmetric treatment—allowing losses but not recoveries—introduces a conservative bias into the accounting. For users of financial statements, a large impairment charge often signals a fundamental deterioration in the prospects of the investee, prompting scrutiny of the investor's capital allocation decisions and the future income stream from the investment, as the lowered carrying basis will also reduce the investor's future share of the investee's profits recognized under the equity method.

References

Related Questions